Likewise, Shimizu et al. [13] showed that the co-expression of ERC/mesothelin and CA125/MUC16 enhances migration and invasion of pancreatic ductal adenocarcinoma and is related to a poor prognosis. Here, MUC16 is linked to pancreatic ductal adenocarcinoma.